CSDX CS Diagnostics Corp.

Fundamentals / CIK 0001106861 / USD

CS Diagnostics Corp. reported $499.4M in total assets through September 30, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CSDX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for CSDX.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2025-09-30 2024-09-30
Revenue $23K $8.0K
Research & Development $0 --
Total Operating Expenses $23K $7.4K
Operating Income -$182 $536
Net Income -$182 $536
Basic EPS $0.00 $0.00
Diluted EPS $0.00 $0.00
Basic Shares Outstanding 137.4M 129.8M
Diluted Shares Outstanding 137.4M 129.8M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for CSDX.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-09-30 2024-12-31
Cash & Cash Equivalents $13 $501
Cash & Short-Term Investments $13 $501
Total Current Assets $31K $501
Total Non-Current Assets $499.4M $499.4M
Total Assets $499.4M $499.4M
Accounts Payable $1.6K $1.4K
Total Liabilities $1.6K $1.4K
Common Stock $1.4K $1.4K
Retained Earnings -$4.74M -$4.77M
Total Stockholders' Equity $499.4M $499.4M
Total Equity $499.4M $499.4M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for CSDX.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2025-09-30
Net Income -$182

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for CSDX.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2025-09-30 2024-09-30
Revenue Growth (YoY) +189.4% --
Operating Income Growth (YoY) -134.0% --
Net Income Growth (YoY) -134.0% --
Source: SEC EDGAR CompanyFacts (CIK 0001106861) · from September 30, 2024 Data through September 30, 2025 · synced Nov 21, 2026, 05:11 UTC · Open in terminal